Ilsung Pharm (003120) — Long-term Investment Intensity
Ilsung Pharm (003120) has a Long-term Investment Intensity of 18.7% as of December 2019. Long-term investments of ₩69.18 Billion represent 18.7% of total assets of ₩369.52 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Ilsung Pharm total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Ilsung Pharm Long-term Investment Intensity (2013–2019)
This chart shows how Ilsung Pharm's Long-term Investment Intensity has evolved across 7 annual periods from 2013 to 2019. As of December 2019, the intensity stands at 18.7%, reflecting long-term investments of ₩69.18 Billion against total assets of ₩369.52 Billion KRW. Explore Ilsung Pharm (003120) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Ilsung Pharm (2013–2019)
The table below presents the year-by-year Long-term Investment Intensity for Ilsung Pharm from 2013 to 2019, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market value of Ilsung Pharm.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 18.7% | ₩69.18 Billion | ₩369.52 Billion | ▲ +7.7 pp |
| 2018 | 11.0% | ₩38.35 Billion | ₩347.26 Billion | ▼ -0.7 pp |
| 2017 | 11.7% | ₩40.80 Billion | ₩347.46 Billion | ▲ +0.2 pp |
| 2016 | 11.6% | ₩39.14 Billion | ₩338.50 Billion | ▲ +1.8 pp |
| 2015 | 9.7% | ₩35.71 Billion | ₩367.03 Billion | ▼ -44.7 pp |
| 2014 | 54.5% | ₩206.06 Billion | ₩378.37 Billion | ▲ +0.0 pp |
| 2013 | 54.5% | ₩202.93 Billion | ₩372.66 Billion | — |